drugset / Trial / NCT00674661
Corneal Collagen Cross-Linking for Ectasia (CXL)
RandomizedParallel-groupOpen-labelTreatment
Summary
Prospective, randomized multicenter study to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes with ectasia after refractive surgery.
Timeline
- Start
- 2007-12
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Riboflavin | Other / unclassified | 0.1 % | — |
| Comparator | Riboflavin | Other / unclassified | 1.6 ml | — |